nach oben

Clinical Rheumatology

Erschienen in:

19.09.2020 | Original Article

Fibromyalgia in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: prevalence and screening

verfasst von: Yirong Xiang, Rui Jiao, Yihan Cao, Dongfeng Liang, Weihong Zhang, Yanying Yu, Wen Zhang, Chen Li

Erschienen in: Clinical Rheumatology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To explore the prevalence, clinical characteristics, and screening strategy for fibromyalgia (FM) in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.

Methods

A total of 313 patients from a cohort of 354 SAPHO patients volunteered to participate in this study. Demographic, clinical and laboratory data were collected at baseline. Acute-phase reactants during the last 3 months were obtained. Patient-reported outcomes (PROs) and FM evaluation were recorded by questionnaires.

Results

A total of 57 (18.2%) patients met the 2016 research criteria for FM. Compared to those without FM, these patients had significantly higher visual analog scale (VAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) scores (all p < 0.001). However, no differences in the erythrocyte sedimentation rate (ESR) or hypersensitive C-reactive protein (hs-CRP) levels were identified between the two groups. Patients with FM were also markedly older [odds ratio (OR) 1.072, p = 0.032] and had higher Fibromyalgia Rapid Screening Tool (FiRST) scores (OR 1.607, p = 0.016). The FiRST score showed a sensitivity of 50.9% and a specificity of 89.8%, and with a cutoff of 3, the FiRST score presented a high sensitivity of 84.2%.

Conclusion

The prevalence of FM among SAPHO patients was similar to that among patients with other rheumatic diseases. Concomitant FM in SAPHO syndrome was associated with older age and worse PROs. Different cutoff values for FiRST screening should be used in patients with SAPHO syndrome.

Key Points

• The prevalence of FM among SAPHO patients was similar to that among patients with other rheumatic diseases.

• Concomitant FM in SAPHO syndrome was associated with older age, widespread pain, and worse PROs.

• Different cutoff values for FiRST screening should be used in patients with SAPHO syndrome

Hayem G (2007) Valuable lessons from SAPHO syndrome. Joint Bone Spine 74(2):123–126. https://doi.org/10.1016/j.jbspin.2006.06.006CrossRefPubMed

Li C, Zuo Y, Wu N, Li L, Li F, Zhang W, Xu W, Zhao X, Jing H, Pan Q, Zhou W, Shi X, Fan Y, Wang J, Liu S, Liu Z, Zhang F, Zeng X, Chen H, Zhang S, Liu J, Qiu G, Wu Z, Dong Z, Zhang W (2016) Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a single centre study of a cohort of 164 patients. Rheumatology (Oxford) 55(6):1023–1030. https://doi.org/10.1093/rheumatology/kew015CrossRef

Salles M, Olive A, Perez-Andres R, Holgado S, Mateo L, Riera E, Tena X (2011) The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol 30(2):245–249. https://doi.org/10.1007/s10067-010-1560-xCrossRefPubMed

Yunus MB (2012) The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012:584573–584578. https://doi.org/10.1155/2012/584573CrossRefPubMed

Assumpcao A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA, Marques AP (2009) Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 10:64. https://doi.org/10.1186/1471-2474-10-64CrossRefPubMedPubMedCentral

Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubere JP, Le Lay K, Taieb C, Matucci-Cerinic M (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39(6):448–453. https://doi.org/10.1016/j.semarthrit.2008.12.003CrossRefPubMed

Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A (2014) Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 34(9):1275–1280. https://doi.org/10.1007/s00296-014-2972-8CrossRefPubMed

Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO (2018) Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis 21(3):639–646. https://doi.org/10.1111/1756-185X.13055CrossRefPubMed

Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA (2015) A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther 17:11. https://doi.org/10.1186/s13075-015-0525-5CrossRefPubMedPubMedCentral

10.

Coskun Benlidayi I (2020) Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases. Rheumatol Int 40:849–858. https://doi.org/10.1007/s00296-019-04506-2CrossRefPubMed

11.

Mease PJ (2017) Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 29(4):304–310. https://doi.org/10.1097/BOR.0000000000000388CrossRefPubMed

12.

Perrot S, Bouhassira D, Fermanian J, Cercle d’Etude de la Douleur en R (2010) Development and validation of the fibromyalgia rapid screening tool (FiRST). Pain 150(2):250–256. https://doi.org/10.1016/j.pain.2010.03.034CrossRefPubMed

13.

Dougados M, Logeart I, Szumski A, Coindreau J, Jones H (2017) Evaluation of whether extremely high enthesitis or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores suggest fibromyalgia and confound the anti-TNF response in early non-radiographic axial spondyloarthritis. Clin Exp Rheumatol 35 Suppl 105(3):50–53PubMed

14.

Meghnathi B, Claudepierre P, Dougados M, Molto A (2018) Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-alpha blockers treatment. Clin Exp Rheumatol 36(6):1043–1048PubMed

15.

Cao Y, Li C, Xu W, Wu X, Sun X, Zhang W, Jing H, Gu Z, Yuan S, Li L, Zuo Y, Liu J, Wu Z, Dong Z, Hao W, Zhang W, Wu N (2019) Spinal and sacroiliac involvement in SAPHO syndrome: a single center study of a cohort of 354 patients. Semin Arthritis Rheum 48(6):990–996. https://doi.org/10.1016/j.semarthrit.2018.09.004CrossRefPubMed

16.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B (2016) 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46(3):319–329. https://doi.org/10.1016/j.semarthrit.2016.08.012CrossRefPubMed

17.

Salaffi F, Di Carlo M, Arcà S, Galeazzi M (2018) Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy. Clin Exp Rheumatol 36(6):1074–1081PubMed

18.

Fitzcharles MA, Perrot S, Hauser W (2018) Comorbid fibromyalgia: a qualitative review of prevalence and importance. Eur J Pain 22(9):1565–1576. https://doi.org/10.1002/ejp.1252CrossRefPubMed

19.

Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F (2014) Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 34(8):1103–1110. https://doi.org/10.1007/s00296-014-2955-9CrossRefPubMed

20.

Wach J, Letroublon MC, Coury F, Tebib JG (2016) Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol 43(11):2056–2063. https://doi.org/10.3899/jrheum.160104CrossRefPubMed

21.

Almodovar R, Carmona L, Zarco P, Collantes E, Gonzalez C, Mulero J, Sueiro JL, Gratacos J, Torre-Alonso JC, Juanola X, Batlle E, Ariza R, Font P (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):S33–S39PubMed

22.

Duffield SJ, Miller N, Zhao S, Goodson NJ (2018) Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 57(8):1453–1460. https://doi.org/10.1093/rheumatology/key112CrossRef

23.

Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St Sauver J (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res 65(5):786–792. https://doi.org/10.1002/acr.21896CrossRef

24.

Rahman A, Underwood M, Carnes D (2014) Fibromyalgia. BMJ 348:g1224. https://doi.org/10.1136/bmj.g1224CrossRefPubMed

25.

Fan A, Tournadre A, Pereira B, Tatar Z, Couderc M, Malochet-Guinamand S, Mathieu S, Soubrier M, Dubost JJ (2016) Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases. Rheumatology (Oxford) 55(10):1746–1750. https://doi.org/10.1093/rheumatology/kew244CrossRef

Titel: Fibromyalgia in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: prevalence and screening
verfasst von: Yirong Xiang
Rui Jiao
Yihan Cao
Dongfeng Liang
Weihong Zhang
Yanying Yu
Wen Zhang
Chen Li
Publikationsdatum: 19.09.2020
Verlag: Springer International Publishing
Erschienen in: Clinical Rheumatology / Ausgabe 4/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05394-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Fibromyalgia in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: prevalence and screening

Abstract

Objective

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis

Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study

Enthesitis may be one of the signs of severe disease in familial Mediterranean fever

Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis

Maintenance to target was associated with radiological outcomes in patients with rheumatoid arthritis: a real-world observational cohort study

The usefulness and validity of English-language videos on YouTube as an educational resource for spondyloarthritis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin